Drugs / Epirubincin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02842099 Background | Jan 2014 → Jan 2020 | breast cancer | Peking Union Medical College Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Epirubincin | “Taxol, Epirubincin, with or without Cyclophosphamide” NCT02842099 ↗ |